Dr. Henry Lin is a Professor of Pediatrics in the UCLA David Geffen School of Medicine. He helps lead the Multi-Ethnic Study of Atherosclerosis (MESA) in large consortium-driven, genomic studies involving ECG traits and atrial fibrillation. Through his efforts over the past 5 years, MESA participated in >35 genomic studies on ECG traits (e.g., heart rate, PR, QRS, QT, ectopy, and atrial fibrillation). Dr. Lin is also member of the NHLBI TOPMed ECG/Arrhythmia working group.
Dr. Lin also conducts research related to genetic epidemiology and mouse models of colorectal cancer. His lab discovered the first gene-diet interaction involved in cancer predisposition. The interaction involves the glutathione transferase M1 null genotype and isothiocyanates (found in cruciferous vegetables). Later, his lab developed the concept of prostaglandin D2 as a tumor-preventing molecule.